Vivanza Biosciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 65.62 million compared to INR 58.6 million a year ago. Revenue was INR 65.79 million compared to INR 58.71 million a year ago. Net income was INR 2.06 million compared to INR 4.58 million a year ago. Basic earnings per share from continuing operations was INR 0.05 compared to INR 0.11 a year ago. Diluted earnings per share from continuing operations was INR 0.05 compared to INR 0.11 a year ago.
For the nine months, sales was INR 234.13 million compared to INR 95.69 million a year ago. Revenue was INR 234.96 million compared to INR 99.2 million a year ago. Net income was INR 9.61 million compared to INR 7.02 million a year ago. Basic earnings per share from continuing operations was INR 0.24 compared to INR 0.18 a year ago. Diluted earnings per share from continuing operations was INR 0.24 compared to INR 0.18 a year ago.